The promise of nanomedicine for ocular disease-Reference-Cited by-同舟云学术

The promise of nanomedicine for ocular disease

Published:2009-08 Issue:6 Volume:4 Page:599-604
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Thomson Heather¹,Lotery Andrew²

Affiliation:

1. Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, SO16 6YD, UK

2. Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, SO16 6YD, UK and Southampton Eye Unit, Southampton General Hospital, Southampton, SO16 6YD, UK.

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm.09.43

Reference49 articles.

1. Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis

2. Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

3. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

4. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

5. Ranibizumab for Neovascular Age-Related Macular Degeneration

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new era in posterior segment ocular drug delivery: Translation of systemic, cell-targeted, dendrimer-based therapies;Advanced Drug Delivery Reviews;2023-09

2. Improving Human Health at the Atomic Level: A Bibliographic Survey of Nanomedicine;SSRN Electronic Journal;2016

3. Correlation of platelet activating factor and age-related macular degeneration;Expert Opinion on Therapeutic Targets;2014-07-31

4. Quality Standards and Current Status of Ophthalmic Formulations in Indian Pharmacopoeia and National Formulary of India;Therapeutic Innovation & Regulatory Science;2014-05

5. Nanotechnology Applications in Ophthalmology;The Clinical Nanomedicine Handbook;2013-10-10